BioCentury
ARTICLE | Clinical News

Sublivac FIX Phleum pratense: Completed Phase II enrollment

December 24, 2012 8:00 AM UTC

HAL Allergy completed enrollment of over 250 patients with persistent allergic rhinitis or rhinoconjunctivitis in the double-blind, placebo-controlled, European Phase II trial evaluating Sublivac FIX ...